Biotheranostics stock

WebBiotheranostics is a molecular diagnostics company that develops and provides diagnostic, prognostic, and predictive tests that helps physicians in the treatment of cancer patients. It offers CancerTYPE ID, a gene expression test for metastatic patients with diagnostic ambiguity, and Breast Cancer Index, a tool for breast cancer patients. Web2 days ago · All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ...

Hologic : to Acquire Biotheranostics, Leader in Molecular Tests for ...

WebMar 11, 2024 · News for Hologic Stock (HOLX) Hologic Stock Sees Composite Rating Climb To Lofty 96. Investors Business Daily • 03/17/21. Top-Rated Stocks: Hologic Sees Composite Rating Climb To 96 ... Hologic Completes Acquisition of Biotheranostics, Enabling Entry into Growing Oncology Market. Business Wire • 02/22/21. Is Hologic … WebFeb 23, 2024 · February 23, 2024 By Sean Whooley. Hologic (NSDQ: HOLX) announced that it completed its previously announced acquisition of Biotheranostics for $230 million. Marlborough, Mass.-based Hologic last ... chinchwad 1rk flat rent https://clickvic.org

Hologic To Buy Biotheranostics For $230M; Top Analyst …

WebBiotheranostics is a commercial-stage molecular diagnostics company that develops and provides diagnostic, prognostic, and predictive tests that support physicians in the treatment of cancer patients. Biotheranostics … WebJan 5, 2024 · BioTheranostics's latest funding round was a Acquired for on January 5, 2024. BioTheranostics's valuation in January 2016 was $94.01M. BioTheranostics's … WebDec 11, 2024 · San Diego, CA, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Biotheranostics, Inc., announces the launch of its Not Another Minute campaign, revealing how Breast Cancer Index (BCI) is changing the game for early-stage, hormone receptor-positive (HR+) breast cancer patients. At the 42nd annual San Antonio Breast Cancer Symposium … grand canyon college basketball scores

Biotheranostics Inc. to Pay $2 Million Settlement …

Category:Biotheranostics Announces Inclusion of Breast Cancer Index in the ...

Tags:Biotheranostics stock

Biotheranostics stock

Biotheranostics, Inc. Announces Several Data Disclosures at

WebJan 5, 2024 · Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million, subject to working capital and other customary closing … WebJan 6, 2024 · Biotheranostics is a privately-held company that sells molecular diagnostics tests for breast and metastatic cancers. Hologic said the company generated about $33 …

Biotheranostics stock

Did you know?

WebJan 8, 2024 · Hologic, Inc. HOLX recently announced its plans to acquire Biotheranostics, Inc., a privately held commercial-stage company providing molecular diagnostic tests for … WebJun 29, 2024 · The Breast Cancer Index test, made by Biotheranostics, analyzes the activity of 11 genes to help predict the risk of early-stage, hormone-receptor-positive breast cancer coming back 5 to 10 years after diagnosis. The test can help women and their doctors decide if extending hormonal therapy 5 more years (for a total of 10 years of …

WebContact Information. 9640 Towne Centre Dr #200. San Diego, CA 92121. Visit Website. Email this Business. (877) 886-6739. WebJan 19, 2024 · Biotheranostics, Inc., is a leading healthcare provider in the oncology field assisting physicians in the treatment of cancer patients. ... The bank suspended its …

WebMar 30, 2024 · Dirix LY, Takacs I, Jerusalem G, Nikolinakos P, Arkenau HT, Forero-Torres A, Boccia R, Lippman ME, Somer R, Smakal M, Emens LA, Hrinczenko B, Edenfield W, Gurtler J, von Heydebreck A, Grote HJ, Chin K, Hamilton EP. Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b … Web(See HOLX stock analysis on TipRanks) Following the deal, Needham analyst Michael Matson said, “HOLX is a leader in the infectious disease testing market and we believe …

WebTheranos Inc. (/ ˈ θ ɛr. ə n. oʊ s /) was an American privately held corporation that was touted as a breakthrough health technology company. Founded in 2003 by then 19-year-old Elizabeth Holmes, Theranos raised more than US$700 million from venture capitalists and private investors, resulting in a $10 billion valuation at its peak in 2013 and 2014. The …

WebAdaptive Biotechnologies (NASDAQ: ADPT) focuses on immuno-sequencing diagnostics, specifically in oncology. It studies and researches sequencing to profile T-Cell and B-Cell Receptors. It incorporates immuno-sequencing into clinical care for diagnosis, prognosis, and monitoring of cancer patients. The company was founded in 2009 and is based in ... grand canyon copper ceramic tileWebJan 6, 2024 · Published. Jan 6, 2024 1:28AM EST. M edical technology company Hologic Inc. has announced the acquisition of privately-held Biotheranostics Inc. in a deal worth … grand canyon colorado woman faWebFeb 21, 2024 · This report contains market sizing and forecasts for this important area of molecular testing, including the following global market information: Global Molecular Cancer Diagnostics Market, 2024 ... grand canyon colorado river tripsWebFeb 22, 2024 · - Breast Cancer Index ™ Added to National Comprehensive Cancer Network Guidelines to Predict Benefit from Extended Endocrine Therapy - Hologic, Inc. (Nasdaq: … grand canyon computer backgroundWebBioTheranostics General Information. Description. Developer of commercial-stage molecular diagnostics intended to guide cancer treatment. The company develops and … grand canyon coloring bookWebBiotheranostics was acquired by Hologic in February 2024, and continues to offer its portfolio of proprietary genomic assays to support personalized disease management in oncology. Visit Hologic.com . Biotheranostics Nondiscrimination Notice. Download our PDF to view this notice in … grand canyon compendiumWebJan 5, 2024 · Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial … grand canyon conservancy field institute